NDC product
CAPSULE · Elysium Pharmaceuticals Limited
NDC 14803-903 · Elysium Pharmaceuticals Limited
Key facts
| Product NDC | 14803-903 |
|---|---|
| Nonproprietary name | Diphenhydramine Hydrochloride |
| Substances | DIPHENHYDRAMINE HYDROCHLORIDE |
| Dosage form | CAPSULE |
| Labeler | Elysium Pharmaceuticals Limited |
| Product type | HUMAN OTC DRUG |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Nov 26, 2020 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: